MZ Associates Inc.



Editor: Zagaria MA, ed. Polypharmacy. Clin Geriatr Med. 2017. May; 33(2). 153-292. ISBN Number 9780323528405 E-ISBN 9780323528412

Preface: Zagaria MA. Inroads into Polypharmacy: Moving Forward with Tools, Deprescribing, and Philosophical Reflection. Clin Geriatr Med. 2017 May;33(2):ix-x. doi: 10.1016/j.cger.2017.02.001. Epub 2017 Feb 23. PMID: 28364997

Editorial (Invited): Zagaria MA. Innovation: The promise of financial viability for pharmacy practice opportunities. Journal of Pharmacy Practice and Research (JPPR), official journal of the Society of Hospital Pharmacists of Australia (SHPA). 2015;45(3):259-260. 

Author: Articles, invited editorials, book chapters, preface, and introductions; inaugurated both the Issues in Pharmacotherapy column in the American Journal for Nurse Practitioners and the monthly Senior Care pharmacy column in the national, peer-reviewed journal U.S. Pharmacist; continues pharmacy column quarterly, to date.


1.     Zagaria MA. Small-Intestine Cancer, IBD, and the Role of Gut Dysbiosis. US Pharm. 2018;43(12): 8-10

2.     Zagaria MA. Nuances of diabetic foot osteomyelitis in older adults. US Pharm. 2018;43(10):10-12.

3.     Zagaria MA. Treatment nuances for Kaposi sarcoma in older adults. US Pharm. 2018;43(8): 8-11.

4.     Zagaria MA.  Nonopioid analgesia following soft-tissue–tumor surgery. US Pharm. 2018;43(6): 6,8-10.

5.     Zagaria MA. Risk of Osteomyelitis with Joint Replacement. US Pharm. 2018;43(4):16-18.

6.     Zagaria MA. Cardiovascular Considerations With Prescription Opioids for Chronic Pain. US Pharm. 2018;43(2):6-9.

7.     Zagaria MA. Chronic Pancreatitis Pain: Opioid and Vitamin D Considerations. US Pharm. 2017:42(12):6-8.

8.     Zagaria MA. U.S. Medical Product Integrity: Protecting Older Adults.  US Pharm. 2017;42(10):8-10.

9.     Zagaria MA. Nocturia in Older Adults: Highlighting Nocturnal Polyuria. US Pharm. 2017;42(8):Epub

10.   Zagaria MA. Medication Therapy Management: Status Overview, Innovation, and Practice Resources. US Pharm. 2017;42(6):7-9.

11.   Zagaria MA, ed. Polypharmacy. Clin Geriatr Med. 2017. May; 33(2). 153-292. ISBN Number 9780323528405 E-ISBN 9780323528412

12.   Zagaria MA. Inroads into Polypharmacy: Moving Forward with Tools, Deprescribing, and Philosophical Reflection. Clin Geriatr Med. 2017 May;33(2):ix-x. doi: 10.1016/j.cger.2017.02.001. Epub 2017 Feb 23. PMID: 28364997

13.   Zagaria MA. Migraine Headache: Connection to TIA and Ischemic Stroke? US Pharm. 2017;42(4)4-7.

14.   Zagaria MA. Myocardial Infarction in Women: Milder Symptoms, Aspirin, and Angioplasty. US Pharm. 2017;42(2):5-7.

15.   Zagaria MA. Late-onset myasthenia gravis: Fatigability and fluctuating weakness. US Pharm. 2017;42(1)4-6.

16.   Zagaria MA. Symptomatic bradycardia: Ophthalmic beta-blockers in older adults. US Pharm. 2016;41(10):15-17.   

17.   Zagaria MA. Ovarian cancer: Treatment considerations in older women. US Pharm. 2016;41(9):18-20. 

18.   Zagaria MA. OTC analgesic use in older adults: Keeping kidneys healthy. US Pharm. 2016;41(8):7-9. 

19.   Zagaria MA. Systemic corticosteroid-associated psychiatric adverse effects. US Pharm. 2016;41(7):16-18. 

20.   Zagaria MA. Polymyalgia rheumatica: Sudden pain and stiffness in seniors. US Pharm. 2016;41(6):27-29. 

21.   Zagaria MA. Male Preconception Health: Impact of Age, Medications, and Other ExposuresUSPharm. 2016;41(5):15-17.  

22.   Zagaria MA. Postoperative Endophthalmitis After Cataract Surgery. US Pharm. 2016;41(4):8,10-11.  

23.   Zagaria MA. Central Poststroke Pain Syndrome. US Pharm. 2016;41(3):21-23. 

24.   Zagaria MA. Periodontitis Risk for AtheroscleroticVascular Disease? US Pharm. 2016;41(2):9-11.

25.   Zagaria MA. Hearing Impairment Age- and Drug-Related Causes.US Pharm. 2016;41(1):19-21.

26.   Zagaria MA. Healthy Aging Raising Nutritional Awareness for Seniors. US Pharm. 2015;40(12):13-15.

27.   Zagaria MA. Recognizing Antipsychotic-Induced Movement Disorders. US Pharm. 2015;40(11):22-25.

28.   Zagaria MA. Brexpiprazole: A newly approved atypical antipsychotic agent. US Pharm. 2015;40(10):13-15.

29.   Zagaria MA. (Invited Editorial). Innovation: The promise of financial viability for pharmacy practice opportunities. Journal of Pharmacy Practice and Research, official journal of the Society of Hospital Pharmacists of Australia (SHPA). 2015;45(3):259-260. 

30.   Zagaria MA. Intimate partner violence: Empathy and a patient-centered approach. US Pharm. 2015;40(9):20-23. 

31.   Zagaria MA. Genitourinary syndrome of menopause: Vaginal estrogen for urinary symptoms. US Pharm. 2015;40(8):8,10,11.

32.   Zagaria MA. Central sleep apnea: Impact of opioids, benzodiazepines, and CYP3A4 inhibitors. US Pharm. 2015;40(7):21-24.

33.   Zagaria MA. Heel and Back-of-the-foot pain in older adults. US Pharm. 2015;40(6):9-11.

34.   Zagaria MA. Age-related sarcopenia. US Pharm. 2015;40(5):16-18.

35.   Zagaria MA. HSV Keratitis: An Important Infectious Cause of Blindness. US Pharm. 2015;40(4):16-18.

36.   Zagaria MA. Periodic Limb Movement Disorder, Restless Legs Syndrome, and Pain. US Pharm. 2015;40(3):19-21.

37.   Zagaria MA. Subclinical hypothyroidism: Risk of Cardiovascular Events. US Pharm. 2015;40(2):27-30.

38.   Zagaria MA. Questionable medication benefit in advanced dementia: Decision-making tools. US Pharm. 2015;40(1):21-23.  

39.   Zagaria MA. Fecal transplantation for recurrent Clostridium difficile infection. US Pharm. 2014;39(12):20-22. 

40.   Zagaria MA. Borderline personality disorder in late life: A medication adherence variable. US Pharm. 2014;39(11):25-28. 

41.   Zagaria MA. Academic detailing: Accurate, relevant, balanced, and engaging. US Pharm. 2014;39(10):16-19. 

42.   Zagaria MA. Risks for endometrial cancer: Obesity, hypertension, and diabetes. US Pharm. 2014;39(9):30,32-33.

43.   Zagaria MA. Urinary incontinence: Urologic and medication etiology in seniors. US Pharm. 2014;39(8):20-23.   

44.   Zagaria MA. Recognizing causes of dyspnea to prevent hospital admissions. US Pharm. 2014;39(7):16-18.

45.   Zagaria MA. Metatarsophalangeal Osteoarthritis: Pain in the Big Toe Joint. US Pharm. 2014;39(6):31-33.

46.   Zagaria MA. Geriatric emergency department care: The pharmacist’s role. US Pharm. 2014;39(5):18-21.

47.   Zagaria MA. Hepatitis C Alert: Baby Boomers Should Be Tested. US Pharm. 2014;39(4):18-20. 

48.   Zagaria MA. Metrics to Define and Measure Quality Pain Management. US Pharm. 2014;39(3):18-21.

49.   Zagaria MA. Mechanical Heart Valves: Contraindication for Dabigatran Therapy. US Pharm. 2014;39(2)32-34.        .

50.   Zagaria MA. Head Injury and Chronic Traumatic Encephalopathy. US Pharm. 2014:39(1):20-23.

51.   Zagaria MA. Inflammatory bowel disease: Nuances of drug therapy in seniors and the role of vitamin D. US Pharm. 2013;38(12):18-20.

52.   Zagaria MA. Bleeding risk with SSRIs: Surgery and seniors. US Pharm. 2013;38(11):20-22. 

53.   Zagaria MA. Rasagiline update: Postmarket evidence and clinical considerations. US Pharm. 2013;38(10):18-20.

54.   Zagaria MA. Access to health care: Influential factors and cultural competence. US Pharm. 2013;38(9):20-22.

55.   Zagaria MA. Nephrotic syndrome: Medication and other related risks. US Pharm. 2013;38(8):18-20.    

56.   Zagaria MAE. Diffuse interstitial lung disease. US Pharm. 2013;38(7):37-39.    

57.   Zagaria MA. Common benign skin growths in older adults. US Pharm. 2013;38(6):37-39.   

58.   Zagaria MA. When communications become difficult: Is it dementia? US Pharm. 2013;38(5):30-32.   

59.   Zagaria MA. Antibiotic therapy: Adverse effects and dosing considerations. US Pharm. 2013:38(4):18-20.

60.   Zagaria MA. Cervical spondylosis: Neck pain, stiffness, ad associated features. US Pharm. 2013;38(3):17-19.

61.   Zagaria MA. Age-associated vulnerability and cardiovascular function: Medication Therapy Management (MTM). US Pharm. 2013;38(2):24-26. 

62.   Zagaria MA. Community-based medication management in the U.S. and Australia. US Pharm. 2013;38(1):16-18.

63.   Zagaria MA. Management of elevated INR secondary to warfarin use: Challenges,recommendations, and resources. Amer J for Nurse Practitioners. 2012;16(11/12):14-16.

64.   Zagaria MA. Laryngopharyngeal reflux (Silent Reflux). US Pharm. 2012;37(12):18-20.

65.   Zagaria MA. Vascular dementia: Potentially preventable cognitive impairment. US Pharm. 2012;37(11):22-24.

66.   Zagaria MA. Focus on the foot: Changes with age and disease. US Pharm. 2012;37(10):20-24.

67.   Zagaria MA. Potentially Inappropriate Medications in Seniors. Amer J for Nurse Practitioners. 2012;16(9/10):26-28.   

68.   Zagaria MA. Alcohol abuse and dependence in senior women: Risks and recommendations. US Pharm. 2012;37(9):22-25.

69.   Zagaria MA. Raising awareness of infectious arthritis. US Pharm. 2012;37(8):23-25.

70.   Zagaria MA. Advance directives for medical decisions. US Pharm. 2012;37(7):20-22. 

71.   Zagaria MA. Medications that worsen and strategies that improve urinary incontinence. US Pharm. 2012;37(6):22-25.

72.   Zagaria MA. Pain as a barrier to exercise for successful aging. US Pharm. 2012;37(5):28-30.

73.   Zagaria MA. Actinic keratosis: Treating a potential malignancy. US Pharm. 2012;37(4):23-26.

74.   Zagaria MA. Long-distance caregiving: Challenges and tips for success. Amer J for Nurse Practitioners. 216(3/4):15-18.   

75.   Zagaria MA. Syncope: Medications as cause and contributing factors. US Pharm. 2012;37(3):22,26-28.

76.   Zagaria MA. Atrial septal defect. US Pharm. 2012;37(2):29-31.

77.   Zagaria MA. Preemptive treatment of constipation when opioids are initiated. US Pharm. 2012;37(1):21-24. 

78.   Zagaria MA. Acute pancreatitis: Risks, causes, and mortality in older adults. US Pharm. 2011;36(12): 24-27. 

79.   Zagaria MA. Treatment decisions in cardiovascular disease: Focus on beta-blockers in seniors. Amer J for Nurse Practitioners. 2011;15(11/12):23-26.  

80.   Zagaria MA. Intellectual disability: Highlighting senior care issues. US Pharm. 2011;36(11):29-34.  

81.   Zagaria MA. Osteoarthritis of the hand: Focus on individualized multimodal therapy. US Pharm. 2011;36(10):22-26.

82.   Zagaria MA. Assessing and monitoring medication therapy in seniors. Amer J for Nurse Practitioners. 2011;15(9/10):48-52.  

83.   Zagaria MA. Urogenital symptoms of menopause: Atrophic vaginitis and atrophic urethritis. US Pharm. 2011;36(9): 22-26.

84.   Zagaria MA. Predisposition to infection in the elderly. US Pharm. 2011;36(8): 28-32.

85.   Zagaria MA. Proton pump inhibitors: Review of benefits and fracture risk. Amer J for Nurse Practitioners. 2011;15(7/8):47-51.  

86.   Zagaria MA. Differential diagnosis of asthma and COPD in older adults: Role of spirometry. US Pharm. 2011;36(7): 20-24. 

87.   Zagaria MA. Drug- and age-related changes in sodium and water regulation. US Pharm. 2011;36(6): 30-33.

88.   Zagaria MA. Postherpetic neuralgia: Seniors at Risk. US Pharm. 2011;36(5): 24-26.

89.   Zagaria MA. Herpes zoster: Treatment modalities and prevention with zoster vaccine. Amer J for Nurse Practitioners. 2011;15(5/6): 46-52.  

90.   Zagaria MA. Graves’ Ophthalmopathy. US Pharm. 2011;36(4):20-29.

91.   Zagaria MA. Lumbar spinal stenosis. US Pharm. 2011;36(3):ahead of print.

92.   Zagaria MA. Antipsychotic-associated metabolic and cardiovascular risks: Monitoring and risk-reduction strategies. Amer J for Nurse Practitioners. 2011;15(3/4):ahead of print.  

93.   Zagaria MA. Aortic stenosis: Evidence supports surgery. US Pharm. 2011;36(2):20-25.

94.   Zagaria MA. Collaborative patient care for seniors with pain. US Pharm. 2011;36(1):21-25.

95.   Zagaria MA. Topical corticosteroids: Focus on appropriate potency and vehicle. Amer J for Nurse Practitioners. 2010;14(11/12):36-40. 

96.   Zagaria MA. Gallstones: Aging and medications increase risk. US Pharm. 2010;35(12):21-24.

97.   Zagaria MA. Common adverse effects of antipsychotic agents in the elderly. US Pharm. 2010;35(11):22-26.

98.   Zagaria MA. Preventing pneumonia in seniors. US Pharm. 2010;35(10):22-25.

99.   Zagaria MA. Sarcopenia: Loss of muscle mass in older adults. US Pharm. 2010;35(9):24-30.

100.  Zagaria MA. Vitamin deficiencies in seniors. US Pharm. 2010;35(8):20-27.        

101.  Zagaria MA. Post-Stroke aspiration pneumonia. US Pharm. 2010;35(7):20-24.            

102.  Zagaria MA. Subclinical hypothyroidism. US Pharm. 2010;35(6):20-22.        

103.  Zagaria MA. Chronic opioid therapy for noncancer pain. US Pharm. 2010;35(5):20-24.      

104.  Zagaria MA. Medications and conditions that potentiate heatstroke: Focus on seniors. Amer J for Nurse Practitioners. 2010;14(5):35-40. 

105.  Zagaria MA. Kaposi’s Sarcoma: Prognosis varies with form. US Pharm. 2010;35(4):20-23.         

106.  Zagaria MA. Hot flashes and night sweats. US Pharm. 2010;35(3): 20-24.       

107.  Zagaria MA. Inhalant agents for asthma, bronchospasm, and COPD: Focus on delivery devices and inhalation technique. Amer J for Nurse Practitioners. 2010;14(3):21-25. 

108.  Zagaria MA. Warfarin in seniors: Reducing Likelihood of harm. US Pharm. 2010;35(2): 2-22.        

109.  Zagaria MA. Common causes of drug-induced seizures. US Pharm. 2010;35(1): 20-23.       

110.  Zagaria MA. Colorectal cancer screening. US Pharm. 2009;34(12): 29-31.   

111.  Zagaria MA. Progressive supranuclear palsy. US Pharm. 2009;34(11): 20-22.       

112.  Zagaria MA. The dying patient: Choices, control, and communication – End-of-Life Care. US Pharm. 2009;34(10): 32-34.         

113.  Zagaria MA. Dyslipidemia: Benefits and risks of statins in primary prevention. Amer J for Nurse Practitioners. 2009;13(10):16-22. 

114.  Zagaria MA. Obesity: Reality and relevance to health. US Pharm. 2009;34(9): 20-24.       

115.  Zagaria MA. Amyloidosis: Interference with organ structure and function. US Pharm. 2009;34(8): 21-24.        

116.  Zagaria MA. Renal dosing: Understanding glomerular filtration rate and estimating creatinine clearance. Amer J for Nurse Practitioners. 2009;13(7/8)32-35. 

117.  Zagaria MA. Raising awareness about pulmonary embolism: Risk and misdiagnosis. US Pharm. 2009;34(7): 24-26.    

118.  Zagaria MA. Caring for the aging: Key health care legislation. US Pharm. 2009;34(6): 22-24.        

119.  Zagaria MA. Assessing pain in the cognitively impaired. US Pharm. 2009;34(5):21-25.       

120.  Zagaria MA. High-alert medications: Resources for NPs. Amer J for Nurse Practitioners. 2009;13(5):21-28. 

121. Zagaria MA. Dermatologic signs of rheumatoid arthritis: Joint and systemic symptoms. US Pharm. 2009;34(4): 22-24.      

122.  Zagaria MA. Vitamin d deficiency and bone pain: Osteomalacia. US Pharm. 20009;34(3): 22-24.

123.  Zagaria MA. Medication-related problems in seniors: Risk factors and tips for appropriate prescribing. Amer J for Nurse Practitioners. 2009;13(3):23-27. 

124.  Zagaria MA. Venous Thrombosis. US Pharm. 2009;34(2): 22-24.

125.  Zagaria MA. Wrist and thumb pain in seniors: Focus on De Quervain’s tenosynovitis. US Pharm. 2009;34(1): 20-22       

126.  Zagaria MA. Antipsychotics in seniors: Warnings to prevent misuse. US Pharm. 2008;33(11):20-22.        

127.  Zagaria MA. ACE inhibitors in hypertension: Dosing, comparisons, and compelling indications. Amer J for Nurse Practitioners. 2008;12(11):26-32. 

128.  Zagaria MA. Nebivolol: New beta-blocker for hypertension. US Pharm. 2008;33(10):20-26.       

129.  Zagaria MA. Health literacy: Striving for effective communication. Amer J for Nurse Practitioners. 2008;12(9):23-26. 

130.  Zagaria MA. Postmenopausal vaginal bleeding. US Pharm. 2008;33(9):28-32.       

131.  Zagaria MA. Sexual activity and STDs among seniors. US Pharm. 2008;33(8):28-30.    

132.  Zagaria MA. Tuberculosis: A preventable cause of death in the elderly. US Pharm. 2008;33(7):23-25.

133.  Zagaria MA. Unintentional acetaminophen overdose: Focus on prevention. Amer J for Nurse Practitioners. 2008;12(6):47-51. 

134.  Zagaria MA. Baby boomers on brink of healthcare crisis. US Pharm. 2008;33(6): 20-26.      

135.  Zagaria MA. Consequences of persistent pain. US Pharm. 2008;33(5):28-30. 

136.  Zagaria MA. Relapsing-remitting multiple sclerosis: Primary and symptomatic management. Amer J for Nurse Practitioners. 2008;12(4):22-26.   

137.  Zagaria MA. Cutaneous adverse reactions: Stevens-Johnson syndrome. US Pharm. 2008;33(4):20-26.       

138.  Zagaria MA. Diverticulitis: Overview and management. US Pharm. 2008;33(3):22-25.

139.  Zagaria MA. Adverse drug effects: Focus on SSRIs. Amer J for Nurse Practitioners. 2008;12(3):34-38. 

140.  Zagaria MA. Warfarin and adverse effects US Pharm. 2008;33(2):22-25.

141.  Zagaria MA. Causes of seizures in the elderly. US Pharm. 2008;33(1):27-31.

142.  Zagaria MA. Pediatric GER & GERD: Overview and management. Amer J for Nurse Practitioners. 2008;12(1):36-42. 

143.  Zagaria MA. GERD update: The refractory patient. US Pharm. 2007;32(12):20-23.

144.  Zagaria MA. Serotonin syndrome US Pharm. 2007;32(11):20-23.

145.  Zagaria MA. Seniors and drug development: Encouraging better communication. US Pharm. 2007;32(10):20-25 .

146.  Zagaria MA. Atypical antipsychotic agents: Monitoring for metabolic syndrome. Amer J for Nurse Practitioners. 2007;11(10):20-26. 

147.  Zagaria MA. Screening for dementia in older females. US Pharm. 2007;32(9):20-25.

148.  Zagaria MA. Anticholinergic adverse effects. Amer J for Nurse Practitioners. 2007;11(9):20-25. 

149.  Zagaria MA. Depression: Suicide’s primary remediable risk factor. US Pharm. 2007;32(8):22-27.    .

150.  Zagaria MA. Pneumoccal Vaccine: Protecting Seniors from Pneumonia. US Pharm. 2007;32(7):22-29.

151.  Zagaria MA. Seniors at Risk for Delirium. US Pharm. 2007;32(6):20-24.

152.  Zagaria MA. A Healthy Tan? Think Again. US Pharm Student Edition. Summer 2007.

153.  Zagaria MA. Geriatric Palliative Care: When the Focus Shifts From Care to Comfort. US Pharm. 2007;32(5):28-34.

154.  Zagaria MA. Chronic and Acute Effects of Sun Exposure on the Skin. US Pharm. 2007;32(4):20-26.

155.  Zagaria MA. Generic Medications: Issues in Senior Care Pharmacy. US Pharm Generic Drug Review. June 2007:14-15.

156.  Zagaria MA. Rate Control in Atrial Fibrillation. US Pharm. 2007;32(2):32-38.

157.  Zagaria MA. Vision, Cognition, and Mobility Challenges for Elderly Drivers. US Pharm. 2007;32(1):36-40.

158.  Zagaria MA. Family Caregiving: Seniors Continue to Receive and Deliver Care. US Pharm. 2006;31(12):23-29.

159.  Zagaria MA. Low Health Literacy: A Safety Concern Among the Elderly. US Pharm. 2006;31(10):28-34.

160.  Zagaria MA. Polypharmacy and Potentially Inappropriate Medication Use in the Elderly: Across the Practice-Setting Spectrum. US Pharm. 2006;31(10):112-116.

161.  Zagaria MA. Persistent Urinary Incontinence in Older Women: Treatment Can Improve Quality of Life. US Pharm. 2006;31(9):20-34.

162.  Zagaria MA. Depression in Older Male Patients. US Pharm. 2006;31(8):34-40.

163.  Zagaria MA. Management of COPD in Seniors. US Pharm. 2006;31(7):28-34.

164.  Zagaria MA. Heat-Related Illnesses in Older Adults: Identifying Potentially Lethal Conditions. US Pharm. 2006;31(6):34-38.

165.  Zagaria MA. Pain Assessment in Older Adults: The Cornerstone of Controlling Pain. US Pharm. 2006;31(5):30-36

166.  Zagaria MA. Xerosis: Treating Clinically Dry Skin. US Pharm. 2006;31(4):28-32.

167.  Zagaria MA. Parkinson’s Disease: Key Points for the Pharmacist. US Pharm. 2006;31(3):20-30.

168.  Zagaria MA. Special considerations for lowering lipids in seniors. US Pharm. 2006;31(2):20-27.

169.  Zagaria MA. Osteoarthritis in Seniors. US Pharm. 2006;31(1):20-24.

170.  Zagaria MA. Sleep Disorders in Senior Women: Diagnosing and Treating a Common Complaint. Women’s Health in Psychiatry. 2006;2(1):14-23.

171.  Zagaria MA. Traumatic Brain Injury in the Elderly. US Pharm. 2005;30(12):20-26.

172.  Zagaria MA. Age-Related Macular Degeneration in the Elderly. US Pharm. 2005;30(11):30-36.

173.  Zagaria MA. Suppressing Gastric Acid in Seniors with GERD. US Pharm. 2005;30(10):34-39.

174.  Zagaria MA. Sleep Disturbances in Older Women: Diagnosing and Treating a Common Complaint. Women’s Health in Primary Care. September 2005;8(8):379-386.

175.  Zagaria MA, Buonanno AP. A Patient-Oriented Approach to the Management of Allergic Rhinitis. Power-Pak C.E. Jobson Publishing Group.  Published September 2005: 1-12.

176.  Zagaria MA. Vaginal Bleeding in Postmenopausal Women. US Pharm. 2005;30(9):22-26.

177.  Zagaria MA. OTC Medication Use in Seniors. US Pharm. 2005;30(8):24-26.

178.  Zagaria MA. Tips for Traveling Seniors. US Pharm. 2005;30(7):32-36.

179.  Zagaria MA. Altered Sleep in Seniors. US Pharm. 2005;30(6):32-38.

180.  Zagaria MA. The Effects of Aging on Drug Efficacy. US Pharm. 2005;30(5):54-57.

181.  Zagaria MA. Medication Therapy Management Services. US Pharm. 2005;30(4):35-42.

182.  Zagaria MA. Abnormal Blood Pressure Homeostasis. US Pharm. 2005;30(3):29-33

183.  Zagaria MA. Geriatric Syndromes. US Pharm. 2005;30(2):29-34.

184.  Zagaria MA. Implications of Dysphagia. US Pharm. 2005;30(1):30-39.

185.  Cooper CB, Zagaria MA. New Advances in the Management of COPD.  Accreditation Council for Pharmacy Education. Program Number: 809-999-05-001-H01. Released January 31, 2005.  

186.  Perfetto E, Barber A, Atkinson W, Zagaria MA. Monitoring and Evaluation: Demonstrating Improved Care Processes and Patient Outcomes. In:  Developing a Senior Care Pharmacy Practice: Your Guide and Tools for Success. 2004. American Society of Consultant Pharmacists. 2004: 123-132

187.  Zagaria MA, Feldman S. Introduction. In: Developing a Senior Care Pharmacy Practice: Your Guide and Tools for Success. 2004. American Society of Consultant Pharmacists. 2004: 5-11.

188.  Zagaria MA. Herpes Zoster, or Shingles, is Painful: Increased Risk in Seniors. US Pharm. 2004;29(12):33-38. 

189.  Zagaria MA. Risk in Clinical Trials Versus Clinical Practice: Drug-Induced Hyperkalemia. US Pharm. 2004;11:29-34

190.  Zagaria MA. Low Health Literacy: Raising Awareness for Optimal Health Communication. US Pharm. 2004;29(10):41-48

191.  Zagaria MA. Carpal Tunnel Syndrome: A Major Entrapment Neuropathy in the Elderly. US Pharm. 2004;29(9):30-36

192.  Zagaria MA. Prevention of Prostate Cancer: Study Investigates Vitamin E and Selenium. US Pharm. 2004;29(8):32-38.

193.  Zagaria MA. Managing the Elderly with Stable COPD. US Pharm. 2004;29(7):32-38. 

194.  Zagaria MA. Pharmacoeconomics in Senior Care: Balancing Costs and Outcomes. US Pharm. 2004;29(6):32-37.

195.  Zagaria MA. Insomnia, Depression, and Suicide Risk in the Elderly. US Pharm. 2004;29(5):30-37

196.  Zagaria MA. Superficial Fungal Infections: Considerations in Treatment Plans. US Pharm. 2004;29(4):20-24.

197.  Zagaria MA. Seniors as Caregivers US Pharm. 2005;29(3):16-25.

198.  Zagaria MA. Recommended screenings for older adults. Modern Pharmacy June  2004;11(6):6-7.

199.  Zagaria MA. Hearing loss in the elderly. Modern Pharmacy. June 2004;11(6):8-10.

200.  Zagaria MA. Aspirin Resistance. US Pharm. 2004;29(2):41-46.

201.  Zagaria MA. The Promise of Pharmacogenomics. US Pharm. 2004;29(1):31-36.

202.  Zagaria MA. Sexually Transmitted Diseases in Older Adults. US Pharm.2003;28(12):26-29.

203.  Zagaria MA. Hyperglycemia Due to Atypical Antipsychotics. US Pharm.2003;28(11):20-23.

204.  Zagaria MA. Transient Ischemic Attacks. US Pharm.2003;28(10):28-31.

205.  Zagaria MA. Dizziness and Vertigo in Seniors. US Pharmacist 2003;28(9):28-32.

206.  Zagaria MA. Benign Prostatic Hyperplasia. US Pharm.2003;28(8):28-34.

207.  Zagaria MA. Common Tremors in the Elderly. Modern Pharmacy 2003;10(8):22-24

208.  Zagaria MA. Aspiration Pneumonia. US Pharm.2003;28(7):28-33.

209.  Zagaria MA. Hemorrhoids: Treatment Options. US Pharm.2003;28(6):28-33.

210.  Zagaria MA. Drug-Induced Acute Renal Failure: Nonsteroidal Anti-Inflammatory Drugs. US Pharmacist 2003;28(5):19-23.

211.  Zagaria MA. Drug-Induced Acute Renal Failure: Angiotensin II Converting Enzyme Inhibitors and Receptor Blockers. US Pharm.2003;28(4):29-33.                                        

212.  Zagaria MA. Lumbar Spinal Stenosis. US Pharm.2003;28(3):28-30.  

213.  Zagaria MA. Hearing Loss in the Elderly. US Pharm.2003;28(2):13-15.  

214.  Zagaria MA. End-of-Life Care in the Elderly. US Pharm.2003;28(1):20-23.  

215.  Zagaria MA. Legal Aspects of Eldercare: The Living Will, Healthcare Proxy and Do-Not-Resuscitate (DNR) Order. US Pharm.2002;27(12):68-69.

216.  Zagaria MA. Appropriate Monitoring Parameters for Epoetin Alfa Therapy for Anemia Associated with Chronic Renal Failure (CRF). US Pharmacist 2002;27(11):52-54.

217.  Zagaria MA. Postherpetic Neuralgia. US Pharm. 2002;27(10):21-23.

218.  Zagaria MA. Visual Consequences of the Aging Eye: Falls and Driving Accidents Among Seniors. US Pharm. 2002;27(8):33-36. 

219.  Zagaria MA. Senior Health Maintenance Part II: Cognitive and Nutritional Fitness. US Pharm. 2002;27(7):21-23.

220.  Zagaria MA. Senior Health Maintenance Part I: Exercise. US Pharmacist. 2002;27(6):35-38.

221.  Zagaria MA. Disinhibition as a Complication of Benzodiazepine Therapy. US Pharmacist. 2002;27(5):37-41.

222.  Zagaria MA. Recommended Screenings for Older Adults. US Pharmacist. 2002;27(3):37-41.

223.  Zagaria MA. Common Tremors in the Elderly: Symptom or Side Effect? US Pharmacist. 2002;27(1):23-28.

224.  Zagaria MA. The Elderly Diabetic and Autonomic Neuropathy. US Pharmacist. 2001;26(11):28-31.

225.  Zagaria MA. Urinary Incontinence:  Care, Complications, and Cost. US Pharmacist. 2001;26(10):28-33.

226.  Zagaria MA. Osteoporosis and Prediction of Fracture Risk. US Pharmacist. 2001;26(09):28-39.

227.  Zagaria MA. Sciatica in Older Adults. US Pharmacist. 2001;26(08):41-46.

228.  Zagaria MA. New Guidelines for Cholesterol Management. US Pharmacist. 2001;26(07):29-33.

229.  Zagaria MA. Pharmacist Interventions Can Prevent Falls. US Pharmacist. 2001;26(05):79-81.

230.  Zagaria MA. TIA, Stroke, and the Importance of Post-Stroke Rehabilitation. US Pharmacist. 2001;26(02):39-40.

231.  Zagaria MA. Alzheimer’s Disease:  Focus on Early Diagnosis and Treatment. US Pharmacist. 2001;26(01):36-40.

232. Zagaria MA. Gestational Diabetes Mellitus:  Risks, Complications, and Therapeutic Outcomes. US Pharmacist. 2000;25(11):50-56.

233.  Zagaria MA. Nutrition in the Elderly:  Undernutrition Perpetuates the Process of Physical, Cognitive, and Functional Decline. US Pharmacist.  2000;25(10):42-44.   

234.   Zagaria MA. Temporal Arteritis: When Headache Can Lead to Blindness. US Pharmacist. 2000;25(9):78-79.

235.  Zagaria MA. Actinic Keratosis: Sun Exposure and Cancer Risk. US Pharmacist. 2000;25(8):25-25.

236.  Zagaria MA. Avoiding Adverse Effects in the Elderly. US Pharmacist. 2000;25(6):73

237.  Zagaria MA. Insomnia in the Elderly. US Pharmacist. 2000;25(5):81

238.  Zagaria MA. Depression: An Under treated Illness. US Pharmacist. 2000;25(4):111

239.  Zagaria MA. Pain Management. US Pharmacist. 2000;25(3):70-73.

240.  Zagaria  ME. Pharmaceutical Care of the Older Patient. US Pharmacist. 2000;25(2):94-97

241.  Zagaria MA1. Quality of life: issues for the pharmacist. Am Pharm. 1995 May;NS35(5):52-7. PMID: 7611140